Related Experiment Videos
[Lymphoid interstitial pneumonia]
W Jodkowski1, J Kuś, D Szymańska
1Z I Kliniki Gruźlicy i Chorób Płuc, Kierownik.
Pneumonologia Polska
|January 1, 1990
Summary
Interstitial lymphoid pneumonia is a rare lung disease diagnosed via lung biopsy. Treatment involves immunosuppression with medications like prednisone, azatioprine, and cyclophosphamide.
Area of Science:
- Pulmonology
- Pathology
- Immunology
Background:
- Interstitial lymphoid pneumonia (ILP) is a rare lung condition.
- It involves diffuse infiltration of lung tissue by lymphocytes and plasmocytes.
- Distinguishing ILP from lymphoid malignancies is crucial.
Observation:
- Diagnosis of ILP requires histopathological examination of biopsied lung tissue.
- The characteristic feature is the diffuse infiltration of lymphocytes and plasmocytes.
- Malignant processes of the lymphatic system present a diagnostic challenge.
Findings:
- Histopathology confirms the diagnosis of interstitial lymphoid pneumonia.
- The infiltrates consist of lymphocytes and plasmocytes.
- Differential diagnosis must exclude lymphoma and other lymphoid malignancies.
Implications:
- Accurate diagnosis through lung biopsy is essential for appropriate management.
- Immunosuppressive therapy is the primary treatment strategy for ILP.
- Pharmacological interventions include prednisone, azatioprine, and cyclophosphamide.